Molecular basis for AU-rich element recognition and dimerization by the HuR C-terminal RRM.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
19 02 2019
Historique:
pubmed: 6 2 2019
medline: 3 5 2019
entrez: 6 2 2019
Statut: ppublish

Résumé

Human antigen R (HuR) is a key regulator of cellular mRNAs containing adenylate/uridylate-rich elements (AU-rich elements; AREs). These are a major class of

Identifiants

pubmed: 30718402
pii: 1808696116
doi: 10.1073/pnas.1808696116
pmc: PMC6386705
doi:

Substances chimiques

3' Untranslated Regions 0
ELAV Proteins 0
ELAV-Like Protein 1 0
RNA-Binding Proteins 0
Tumor Suppressor Proteins 0
ribonucleotide reductase M2 EC 1.17.4.-
RRM1 protein, human EC 1.17.4.1
Ribonucleoside Diphosphate Reductase EC 1.17.4.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2935-2944

Informations de copyright

Copyright © 2019 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Expert Opin Biol Ther. 2007 Oct;7(10):1515-29
pubmed: 17916044
Nucleic Acids Res. 2006;34(17):4943-59
pubmed: 16982642
RNA. 2001 Sep;7(9):1348-61
pubmed: 11565755
J Biol Chem. 2007 Jul 20;282(29):20948-59
pubmed: 17517897
Q Rev Biophys. 2016 Jan;49:e1
pubmed: 26347403
Nucleic Acids Res. 2002 Oct 15;30(20):4519-26
pubmed: 12384599
FEBS J. 2005 May;272(9):2118-31
pubmed: 15853797
J Biomol NMR. 2010 Jan;46(1):11-22
pubmed: 19915800
Nucleic Acids Res. 2008 Mar;36(4):1390-9
pubmed: 18203745
Nucleic Acids Res. 2000 Apr 15;28(8):1743-50
pubmed: 10734193
EMBO J. 1998 Jun 15;17(12):3448-60
pubmed: 9628880
Mol Cell. 2011 Aug 5;43(3):327-39
pubmed: 21723170
Chembiochem. 2004 Oct 4;5(10):1432-47
pubmed: 15457527
Nucleic Acids Res. 2014 Sep;42(15):10173-84
pubmed: 25064856
Mol Cell. 2011 Aug 5;43(3):340-52
pubmed: 21723171
EMBO J. 2018 Mar 15;37(6):
pubmed: 29449323
J Biol Chem. 2017 Oct 13;292(41):16999-17010
pubmed: 28790173
EMBO Rep. 2016 Aug;17(8):1184-203
pubmed: 27402548
Nucleic Acids Res. 1997 Sep 15;25(18):3564-9
pubmed: 9278474
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2987-92
pubmed: 14981256
J Mol Biol. 2009 Feb 20;386(2):435-50
pubmed: 19109971
Genes Dev. 2002 Dec 1;16(23):3087-99
pubmed: 12464637
Mol Cell Biol. 2002 Oct;22(20):7268-78
pubmed: 12242302
Mol Cell. 2014 Feb 6;53(3):506-14
pubmed: 24440503
J Mol Biol. 2007 Sep 21;372(3):774-97
pubmed: 17681537
Proc Natl Acad Sci U S A. 1995 May 9;92(10):4557-61
pubmed: 7753842
Mol Cell Biol. 1993 Jun;13(6):3494-504
pubmed: 8497264
Front Biosci (Landmark Ed). 2012 Jan 01;17:189-205
pubmed: 22201738
Mol Cancer Res. 2011 May;9(5):648-59
pubmed: 21498545
Nat Struct Biol. 2001 Feb;8(2):141-5
pubmed: 11175903
Nat Commun. 2014 Jun 27;5:4190
pubmed: 24969639
Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W496-502
pubmed: 18515350
RNA Biol. 2014;11(10):1250-61
pubmed: 25584704
Elife. 2017 Jun 26;6:
pubmed: 28650318
Acta Crystallogr D Biol Crystallogr. 2013 Mar;69(Pt 3):373-80
pubmed: 23519412
J Cell Biol. 2000 Oct 2;151(1):1-14
pubmed: 11018049
Curr Drug Targets. 2015;16(5):499-515
pubmed: 25706256
Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3073-8
pubmed: 10737787
Nucleic Acids Res. 2012 Jun;40(11):5088-100
pubmed: 22362743
Nature. 2011 Jul 13;475(7356):408-11
pubmed: 21753750
Mol Cell Biol. 2009 May;29(10):2762-76
pubmed: 19307312
Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14085-90
pubmed: 11121017
Int J Mol Sci. 2013 May 10;14(5):10015-41
pubmed: 23665903
Nucleic Acids Res. 1996 Dec 15;24(24):4895-901
pubmed: 9016658
RNA. 2017 Mar;23(3):308-316
pubmed: 28003515
Science. 2005 Sep 23;309(5743):2054-7
pubmed: 16179478
Trends Cell Biol. 2016 Sep;26(9):668-679
pubmed: 27289443
J Am Chem Soc. 2014 Oct 15;136(41):14536-44
pubmed: 25216038
J Cell Sci. 1996 Mar;109 ( Pt 3):579-89
pubmed: 8907704
Wiley Interdiscip Rev RNA. 2010 Sep-Oct;1(2):214-29
pubmed: 21935886
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15293-8
pubmed: 9860962
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D111-4
pubmed: 16381826

Auteurs

Nina Ripin (N)

Department of Biology, Institute of Molecular Biology and Biophysics, ETH Zürich, 8093 Zürich, Switzerland; nina.ripin@mol.biol.ethz.ch nicole.meisner-kober@sbg.ac.at frederic.allain@mol.biol.ethz.ch.
Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland.

Julien Boudet (J)

Department of Biology, Institute of Molecular Biology and Biophysics, ETH Zürich, 8093 Zürich, Switzerland.

Malgorzata M Duszczyk (MM)

Department of Biology, Institute of Molecular Biology and Biophysics, ETH Zürich, 8093 Zürich, Switzerland.

Alexandra Hinniger (A)

Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland.

Michael Faller (M)

Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland.

Miroslav Krepl (M)

Institute of Biophysics, Czech Academy of Sciences, 612 65 Brno, Czech Republic.
Department of Physical Chemistry, Faculty of Science, Regional Centre of Advanced Technologies and Materials, Palacky University Olomouc, 771 46 Olomouc, Czech Republic.

Abhilash Gadi (A)

Department of Microbiology, New York University School of Medicine, New York, NY 10016.

Robert J Schneider (RJ)

Department of Microbiology, New York University School of Medicine, New York, NY 10016.

Jiří Šponer (J)

Institute of Biophysics, Czech Academy of Sciences, 612 65 Brno, Czech Republic.
Department of Physical Chemistry, Faculty of Science, Regional Centre of Advanced Technologies and Materials, Palacky University Olomouc, 771 46 Olomouc, Czech Republic.

Nicole C Meisner-Kober (NC)

Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland; nina.ripin@mol.biol.ethz.ch nicole.meisner-kober@sbg.ac.at frederic.allain@mol.biol.ethz.ch.

Frédéric H-T Allain (FH)

Department of Biology, Institute of Molecular Biology and Biophysics, ETH Zürich, 8093 Zürich, Switzerland; nina.ripin@mol.biol.ethz.ch nicole.meisner-kober@sbg.ac.at frederic.allain@mol.biol.ethz.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH